Shin-Etsu Chemical Co., Ltd. engages in the manufacture and sale of industrial chemicals. Its operations are carried out through the following segments: Polyvinyl Chloride (PVC)/Chlor-Alkali Business, Silicone Business, Specialty Chemicals Business, Semiconductor Silicon Business, Electronics and Functional Materials Business, and Diversified Business. The PVC/Chlor-Alkali Business segment provides PVC, caustic soda, methanol, and chloromethane. The Silicone Business segment provides silicones. The Specialty Chemicals Business segment provides cellulose derivatives, silicon metal, polyvinyl alcohol, and synthetic pheromones. The Semiconductor Silicon Business segment provides silicon wafer products. The Electronics and Functional Materials Business segment provides rare earth magnets, coating materials, photomask blanks, oxide single crystals, and liquid fluoroelastomers. The Diversified Business segment includes processed plastics, international trading, engineering, ad information processing. The company was founded on September 16, 1926 and is headquartered in Tokyo, Japan.

SilcoTek Corp is a private company headquartered in Bellefonte,, that manufactures chemically inert, corrosion resistant and non-stick surfaces. It was founded by Paul H. Silvis.

Central Glass Co., Ltd. engages in production, fabrication, sale and purchase of glass and chemical products. It operates through the following segments: Glass Business and Chemicals Business. The Glass Business segment manufactures and distributes architectural glass, glass products for automobiles and electronic materials. The Chemicals Business segment produces and sells chemical and fine chemical products, fertilizer, and glass fiber. The company was founded on October 10, 1936 and is headquartered in Tokyo, Japan.

Manufactures pharmaceuticals

Applied Materials, Inc. provides manufacturing equipment, services and software to the semiconductor, display and related industries. It operates through the following segments: Semiconductor Systems, Applied Global Services, and Display & Adjacent Markets. The Semiconductor Systems segment includes semiconductor capital equipment for etch, rapid thermal processing, deposition, chemical mechanical planarization, metrology and inspection, wafer packaging, and ion implantation. The Applied Global Services segment provides solutions to optimize equipment, performance, and productivity. The Display & Adjacent Markets segment offers products for manufacturing liquid crystal displays, organic light-emitting diodes, equipment upgrades, and other display technologies for TVs, monitors, laptops, personal computers, smart phones, and other consumer-oriented devices. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Micron manufactures DRAM components and modules and NAND Flash. For more than 30 years, Micron’s teams of dreamers, visionaries, and scientists have redefined innovation—designing and building some of the world’s most advanced memory and semiconductor technologies. They develop the technologies that transform what's possible. In fact, you likely use their memory every day—in products from computing, networking, and server applications, to mobile, embedded, consumer, automotive, and industrial designs. As one of the most prolific patent holders in the world they continually rethink, recast, and advance new ideas to bring innovation to broader markets and find ways their technology can inspire new applications or make fundamental improvements to existing designs. Their roots are in memory, the core strength of their business. As they look toward the future, they’ll continue to build on their past achievements by leveraging the synergies between their core memory business and diversified products and technologies that help drive innovation and growth in new markets.

Tokyo Electron Ltd. engages in the development, manufacture, and sale of semiconductor production equipment and industrial electronics products for flat panel display manufacturing equipment. It operates through the following segments: Semiconductor Production Equipment (SPE), Flat Panel Display (FPD) Production Equipment and Others. The SPE segment handles the development, manufacture, service, and distribution of coaters/developers, plasma etch systems, thermal processing systems, single wafer deposition systems, cleaning systems, wafer probers, and other semiconductor production equipment. The FPD Production Equipment segment manufactures coater/developer for manufacturing flat panel display and Plasma etching/ashing device. The Others segment includes logistics, facilities management, and insurance businesses. The company was founded in November 11, 1963 and is headquartered in Tokyo, Japan.

Wacker GmbH is a German private company located in Berlin. The firm provides investment, property insurance and financing services. It was founded in 2016.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Provides materials management products and solutions

Qinyang Guoshun Silicon Source Photoelectric Gas Co., Ltd., established on 2004-05-24, Business scope includes production and sales of high-purity dichlorosilane,Trichlorosilane,Tetrachlorosilane and other related silicon source gases and electronic materials;Selling Chlorine,Diborane,Phosphine,Arsine,Silane,nitrous oxide,Hexafluoroethane,boron trifluoride,Trifluoromethane,sulfur hexafluoride,carbon dioxide,Nitrogen trifluoride,Nitrogen,Boron trichloride,Ammonia,Argon,hydrogen chloride,Methanol,ethanol,boron bromide,Phosphorus chloride,Phosphine bromide,Arsenic trichloride,hydrogen selenide(Anhydrous);Engaged in the import and export business of the above goods and technologies**(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)

Chisso Corp. engages in the manufacture and sale of chemical products. It offers liquid crystals, polyolefin composite fibers, coated fertilizers, and chemical fertilizers. The company was founded on January 12, 1906 and is headquartered in Tokyo, Japan.

Dow Silicones UK Ltd. manufactures of other inorganic basic chemicals. The company was founded on September 8, 1950 and is headquartered in Barry, the United Kingdom.

Chevron Oronite Technology BV, part of Chevron Corp., is a company headquartered in Rotterdam, the Netherlands, that develops, manufactures & markets performance additives for fuels & lubricating oils.

LG Display is a manufacturer of thin-film transistor liquid crystal display (TFT-LCD) panels, OLEDs and flexible displays. The company began development of TFT-LCD in 1987 and now provides display panels in a wide range of sizes and specifications applying the various cutting-edge technologies such as AH-IPS, FPR 3D, OLED, and Flexible. LG Display currently operates nine fabrication facilities and seven back-end assembly facilities in Korea, China, Poland, and Mexico. In addition, it operates the global network of sales subsidiaries to efficiently service the local markets. As of the end of 2013, 52,000 employees work for LG Display worldwide.

Mitsui & Co is a general trading company. Mitsui & Co's business area covers energy, machinery, chemicals, food, textile, logistics, finance, and more. They will contribute to address diverse industrial needs, through procurement, supply and sales of iron and steel products and investment to processing and distribution businesses in Japan and abroad. Through business development, investment and trading of mineral, metal resources and metals, they reinforce a stable supply of the resources and materials necessary for both industry and society. They are also active in metal recycling and other initiatives to develop industrial solutions to environmental issues. They contribute to creating better lives through the long-term, reliable supply of social infrastructure such as electricity, gas, water,railways and other logistics infrastructure. They provide sales, financing, lease, transportation and logistics, and project investment in a wide range of machineries, including large-scale plants, marine resource development facilities,ships, and aerospace, motor vehicles, construction/mining machinery and industrial machinery. Their chemicals business encompasses trade and investment in a range of industries, from upstream chemicals such as basic chemicals, fertilizer resources, through to downstream chemicals such as functional materials, electronics materials,fertilizers,aguricultural chemicals and specialty chemicals. They are also pursuing new initiatives such as green chemicals. Through upstream development, logistics and trading of energy resources such as oil, natural gas/LNG ,coal and uranium, they contribute to the stable supply of energy vital to both industry and society. As part of efforts to achieve a low-carbon society, they are also actively involved in next-generation energy and environemental businesses. Adapting to changes in consumption and lifestyles while meeting consumers’ diverse needs, they provide value-added products and services, develop businesses and make investments in the fields of food resources, food products, retail support business, medical and healthcare, fashion, forestry plantation resources, real estate-related business. Through their ICT, Finance and Logistics business, they work on a diverse range of projects aimed at developing innovative business and expanding their business field. At the same time, they aim to strengthen their company-wide earnings base by pursuing strategic projects and new opportunities and providing specialized functions that contribute to the whole Mitsui & Co. group. Trading in various commodities led by overseas trading subisidiaries of offices located in the Americas area. Trading in various commodites led by overseas trading subsidiaries or offices located in Europe, the Middle East and Africa area. Trading in various commodities led by overseas trading subsidiaries of offices located in the Asia Pacific area.

MKS Instruments, Inc. provides instruments, systems, subsystems and process control solutions to measure, control, power, monitor, and analyze parameters of manufacturing processes to improve process performance and productivity for its customers. It operates through the following segments: Vacuum & Analysis, Light & Motion and Equipment & Solutions. The Vacuum & Analysis segment comprises pressure measurement and control, flow measurement and control, gas and vapor delivery, gas composition analysis, residual gas analysis, leak detection, control technology, ozone generation and delivery, RF & DC power, reactive gas generation and vacuum technology components. The Light & Motion segment includes lasers, photonics, sub-micron positioning, vibration control, and optics instruments. The Equipment & Solutions segment provides laser-based manufacturing systems solutions for the micro-machining industry that enable customers to optimize production. The company was founded in 1961 and is headquartered in Andover, MA.

Ranbaxy Laboratories Limited, a pharmaceutical company, produces a range of generic medicines. The company has a presence in 49 countries, manufacturing facilities in 11 countries and serves customers in approximately 125 countries. Products The company manufactures and markets generic pharmaceuticals, value added generic pharmaceuticals, branded generics, active Pharmaceuticals (API) and intermediates. Its product basket of approximately 5,000 SKUs available in approximately 125 countries worldwide, encompasses a therapeutic mix covering a majority of the chronic and acute segments. Research & Development The company offers value added formulations based on its Novel Drug Delivery System (NDDS) and New Chemical Entity (NCE) research outcomes. Novel Drug Delivery Systems (NDDS): The company's NDDS focus is mainly on the development of New Drug Applications (NDA) / Abbreviated New Drug Applications (ANDAs) of oral controlled- release products for the regulated markets. Ranbaxy's in-house NDDS programs are primarily focused on the oral segment. Inhalation (patented devices) and trans-dermal (patented adhesive polymers) programs are also being pursued through collaborations. In the oral NDDS space, Ranbaxy has developed four platform technologies namely Gastro Retentive, Modified Matrix, Multiparticulate and AeroGel. New Drug Discovery Research (NDDR): The company's NDDR program focuses on select therapeutic segments of Infectious diseases, Metabolic diseases, Inflammatory/ Respiratory disease and Oncology. The company has 8-10 programs in the area of NDDR. For Arterolane (potential Anti-malarial candidate), the company has obtained approval from the Drug Controller General of India to initiate Phase III human clinical trials in India. The company is also profiling DPP-IV Inhibitors (Di-Peptidyl Peptidase IV Inhibitors) for Type-2-diabetes, a selective Phosphodiesterase 4-b inhibitor for COPD and Asthma, and a novel antibiotic antibacterial for Community Acquired Respiratory Tract Infection. Under an alliance with an academic institution in India, various medicinal plants are being evaluated as potential sources for novel pharmaceutical agents. The company also has collaborative research projects with other academic institutions in India in the area of Respiratory and Infectious disease. Significant Events In June 2008, Ranbaxy entered into an alliance with Daiichi Sankyo Company Ltd., to create a generic pharmaceutical powerhouse. On September 17, 2009, Ranbaxy Laboratories Ltd. has entered into a strategic in-licensing agreement for the Indian market with Medy-Tox Inc. for its cosmetic product, Neuronox. Neuronox is a botulinum toxin type A complex (100 Units) pharmaceutical manufactured by Medy-Tox. History Ranbaxy Laboratories Limited was founded in 1961.